𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Angiokeratomas, Fabry disease and enzyme replacement therapy: still a challenge

✍ Scribed by M. Möhrenschlager; V. Henkel; J. Ring

Book ID
108667947
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
57 KB
Volume
152
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fabry disease: enzyme replacement therap
Fabry disease: enzyme replacement therapy
✍ MR Bongiorno; G Pistone; M Aricò 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB

## ABSTRACT Fabry disease is a multisystem disorder associated with wide variability in clinical expression. Fabry disease is an X‐linked lysosomal storage disorder caused by a deficiency of α‐galactosidase A. The enzyme defect leads to the systemic accumulation of glycosphingolipids with α‐galacto

Enzyme replacement therapy and intraepid
Enzyme replacement therapy and intraepidermal innervation density in Fabry disease
✍ Raphael Schiffmann; Peter Hauer; Barbara Freeman; Markus Ries; Leland J. C. Scot 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

## Abstract We prospectively evaluated the effect of enzyme replacement therapy (ERT) on the intraepidermal nerve fiber density (IENFD) and thermal threshold in patients with Fabry disease, an X‐linked disorder associated with a painful small‐fiber neuropathy and decreased linear IENFD in a length‐